Hangzhou, February 12, 2025 – REACH24H BaiPharm (Ruiou Baiyao (Hangzhou) Pharmaceutical Technology Co., Ltd.) and Accestra Consulting Company (Hangzhou Jingchi Technology Co., Ltd.) are pleased to announce a landmark merger that will further strengthen the delivery of regulatory and compliance services across the pharmaceutical industry. Effective February 12, 2025, this strategic merger integrates Accestra’s technical expertise into BaiPharm’s global service framework, with all services now operating under the established BaiPharm brand.

By combining our strengths, we are poised to offer clients even more comprehensive, efficient, and innovative solutions tailored to meet the complex demands of today’s pharmaceutical regulatory environment.

About REACH24H China

Founded in 2009 and headquartered in Hangzhou, China, REACH24H Consulting Group operates globally with offices in Ireland, the UK, the US, South Korea, Japan, Singapore, and the Taiwan region. The group delivers regulatory consulting and technical services across industries including industrial chemicals, agrochemicals, biocides, cosmetics, food, packaging materials, and pharmaceuticals. With over 300 employees, REACH24H has successfully served more than 15,000 clients worldwide.

About REACH24H BaiPharm

A subsidiary of REACH24H Consulting Group China, BaiPharm specializes in regulatory and technical services for the pharmaceutical industry. The company’s expertise spans pharmaceutical intermediates, active pharmaceutical ingredients (APIs), excipients, packaging materials, and finished dosage forms. It offers comprehensive support—from product registration and pharmacovigilance to GxP compliance consulting, regulatory intelligence, and toxicological assessments—delivered by a team of seasoned experts including pharmacologists, certified toxicologists, former R&D specialists, analytical engineers, regulatory professionals, and GMP inspection experts.

About Accestra Consulting

Accestra Consulting is a trusted regulatory affairs outsourcing partner for the pharmaceutical, medical device, and food industries in China. Headquartered in Hangzhou, Accestra provides tailored regulatory solutions to ensure compliance with China NMPA (formerly CFDA) regulations, facilitating smooth market access. With a proven track record of supporting hundreds of product registrations, the company specializes in China Regulatory Compliance & Pharmacovigilance Services, helping clients navigate complex regulatory requirements to achieve successful commercialization.

Leadership Remarks

Fangwei Hong , General Manager of REACH24H, stated:

“We are delighted to welcome Helen Ye and the Accestra Consulting team into the BaiPharm family. This merger represents a significant step in our journey to enhance service offerings and strengthen our collective expertise. We are confident that, together, we will continue to provide high-quality regulatory and compliance services to our clients, reinforcing our commitment to excellence.”

Liang Hong, CEO of BaiPharm, added:

“We are thrilled to welcome Accestra Consulting into the BaiPharm family. This strategic collaboration enables us to expand our service offerings and reinforces our commitment to delivering top-tier regulatory and technical solutions. Together, we will set new benchmarks in the industry, ensuring our clients receive the highest quality support for their compliance and regulatory needs.”

Helen Ye, CEO of Accestra Consulting, commented:

“This merger marks a significant milestone in Accestra Consulting’s journey. By integrating our expertise with BaiPharm, we can provide even greater value to our clients worldwide. Our shared vision for regulatory excellence and customer service will drive us toward new levels of innovation and efficiency.”

Together, we are committed to redefining excellence in pharmaceutical compliance and technical services. This new chapter reflects our dedication to innovation, quality, and customer-centric solutions. We look forward to a future of strengthened partnerships and unparalleled value for our clients.

Contact Information

If you have any questions about pharmaceutical compliance, please feel free to contact us. Learn more about our ​Pharmaceutical compliance consulting services here.

Phone: +86 571 8700 7555

Email: info@baipharm.com or helen.ye@baipharm.com